日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reply to the letter by Dr Karlsson 'Rationale behind the European Thyroid Association 2024 Guideline to treat the Allan-Herndon-Dudley syndrome with tiratricol?'

回复卡尔森博士的来信“欧洲甲状腺协会 2024 年指南中关于使用替拉曲考治疗 Allan-Herndon-Dudley 综合征的理由是什么?”

Persani, Luca; Rodien, Patrice; Moran, Carla; Visser, W Edward; Groeneweg, Stefan; Peeters, Robin; Refetoff, Samuel; Gurnell, Mark; Beck-Peccoz, Paolo; Chatterjee, Krishna

Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia

Crinecerfont治疗成人先天性肾上腺皮质增生症的3期临床试验

Auchus, Richard J; Hamidi, Oksana; Pivonello, Rosario; Bancos, Irina; Russo, Gianni; Witchel, Selma F; Isidori, Andrea M; Rodien, Patrice; Srirangalingam, Umasuthan; Kiefer, Florian W; Falhammar, Henrik; Merke, Deborah P; Reisch, Nicole; Sarafoglou, Kyriakie; Cutler, Gordon B Jr; Sturgeon, Julia; Roberts, Eiry; Lin, Vivian H; Chan, Jean L; Farber, Robert H

Safety and efficacy of nintedanib as second-line therapy for patients with differentiated or medullary thyroid cancer progressing after first-line therapy. A randomized phase II study of the EORTC Endocrine Task Force (protocol 1209-EnTF)

尼达尼布作为二线治疗方案,用于一线治疗后进展的分化型或髓样甲状腺癌患者的安全性和有效性。欧洲癌症研究与治疗组织内分泌工作组开展的一项随机II期研究(方案1209-EnTF)。

Leboulleux, Sophie; Kapiteijn, Ellen; Litière, Saskia; Schöffski, Patrick; Godbert, Yann; Rodien, Patrice; Jarzab, Barbara; Salvatore, Domenico; Zanetta, Sylvie; Capdevila, Jaume; Bastholt, Lars; De La Fouchardiere, Christelle; Lalami, Yassine; Bardet, Stéphane; Cornélis, Frank; Dedecjus, Marek; Links, Thera; Sents, Ward; Schlumberger, Martin; Locati, D Laura; Newbold, Katie

2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action

2024年欧洲甲状腺协会关于甲状腺激素转运、代谢和作用遗传性疾病的诊断和治疗指南

Persani, Luca; Rodien, Patrice; Moran, Carla; Visser, W Edward; Groeneweg, Stefan; Peeters, Robin; Refetoff, Samuel; Gurnell, Mark; Beck-Peccoz, Paolo; Chatterjee, Krishna

The Severity of Congenital Hypothyroidism With Gland-In-Situ Predicts Molecular Yield by Targeted Next-Generation Sequencing

先天性甲状腺功能减退症伴原位腺体的严重程度可预测靶向二代测序的分子产量

Levaillant, Lucie; Bouhours-Nouet, Natacha; Illouz, Frédéric; Amsellem Jager, Jessica; Bachelot, Anne; Barat, Pascal; Baron, Sabine; Bensignor, Candace; Brac De La Perriere, Aude; Braik Djellas, Yasmine; Caillot, Morgane; Caldagues, Emmanuelle; Campas, Marie-Neige; Caquard, Marylène; Cartault, Audrey; Cheignon, Julie; Decrequy, Anne; Delemer, Brigitte; Dieckmann, Katherine; Donzeau, Aurélie; Doye, Emilie; Fradin, Mélanie; Gaudillière, Mélanie; Gatelais, Frédérique; Gorce, Magali; Hazart, Isabelle; Houcinat, Nada; Houdon, Laure; Ister-Salome, Marielle; Jozwiak, Lucie; Jeannoel, Patrick; Labarthe, Francois; Lacombe, Didier; Lambert, Anne-Sophie; Lefevre, Christine; Leheup, Bruno; Leroy, Clara; Maisonneuve, Benedicte; Marchand, Isis; Marquant, Emeline; Muszlak, Matthias; Pantalone, Letitia; Pochelu, Sandra; Quelin, Chloé; Radet, Catherine; Renoult-Pierre, Peggy; Reynaud, Rachel; Rouleau, Stéphanie; Teinturier, Cécile; Thevenon, Julien; Turlotte, Caroline; Valle, Aline; Vierge, Melody; Villanueva, Carine; Ziegler, Alban; Dieu, Xavier; Bouzamondo, Nathalie; Rodien, Patrice; Prunier-Mirebeau, Delphine; Coutant, Régis

ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial

评估预防性中央区颈部淋巴结清扫术对改善低危分化型甲状腺癌预后的作用:一项前瞻性随机试验

Hartl, Dana; Godbert, Yann; Carrat, Xavier; Bardet, Stéphane; Lasne-Cardon, Audrey; Vera, Pierre; Ilies, Elena; Zerdoud, Slimane; Sarini, Jérôme; Zalzali, Mohamad; La Manna, Luigi; Schneegans, Olivier; Kelly, Antony; Kauffmann, Philppe; Rodien, Patrice; Brunaud, Laurent; Grunenwald, Solange; Housseau, Elie; Laghouati, Salim; Bouvet, Nathalie; Lecerf, Elodie; Hadoux, Julien; Lamartina, Livia; Schlumberger, Martin; Borget, Isabelle

Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)

Selumetinib 联合辅助放射性碘治疗高危分化型甲状腺癌患者:一项 III 期随机安慰剂对照试验 (ASTRA)

Ho, Alan L; Dedecjus, Marek; Wirth, Lori J; Tuttle, R Michael; Inabnet, William B 3rd; Tennvall, Jan; Vaisman, Fernanda; Bastholt, Lars; Gianoukakis, Andrew G; Rodien, Patrice; Paschke, Ralf; Elisei, Rossella; Viola, David; So, Karen; Carroll, Danielle; Hovey, Tina; Thakre, Bhavana; Fagin, James A

Graves' Disease in the Young: Could We Change the Weather?

青少年格雷夫斯病:我们能否改变天气?

Rodien, Patrice

Identification of Dysregulated Expression of G Protein Coupled Receptors in Endocrine Tumors by Bioinformatics Analysis: Potential Drug Targets?

通过生物信息学分析鉴定内分泌肿瘤中G蛋白偶联受体的异常表达:潜在的药物靶点?

Valentine Suteau ,Mathilde Munier ,Rym Ben Boubaker ,Méline Wery ,Daniel Henrion ,Patrice Rodien ,Claire Briet

A Tear Metabolomic Profile Showing Increased Ornithine Decarboxylase Activity and Spermine Synthesis in Thyroid-Associated Orbitopathy

甲状腺相关眼病患者的泪液代谢组学分析显示鸟氨酸脱羧酶活性和精胺合成增加。

Billiet, Benjamin; Chao de la Barca, Juan Manuel; Ferré, Marc; Muller, Jeanne; Vautier, Anaïs; Assad, Sophie; Blanchet, Odile; Tessier, Lydie; Wetterwald, Céline; Faure, Justine; Urbanski, Geoffrey; Simard, Gilles; Mirebeau-Prunier, Delphine; Rodien, Patrice; Gohier, Philippe; Reynier, Pascal